Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 563-569

  Reffelmann, Thorsten ^a   Dörr, Marcus ^a   Ittermann, Till ^b   Schwahn, Christian ^b   Völzke, Henry ^b   Ruppert, Jörg ^a   Robinson, Daniel ^a   Felix, Stephan B ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Arterial hypertension; Blood pressure; Epidemiology; Hypertrophy; Left ventricular mass; Magnesium

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; LOOP DIURETIC AGENT; MAGNESIUM; MOXONIDINE; RESERPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LONGITUDINAL STUDIES; MAGNESIUM; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 78649747300     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.08.073     Document Type: Article

References (26)

1. Kannel W.B., Cobb J. Left ventricular hypertrophy and mortality: results from the Framingham Study. Cardiology 1992, 81:291-298.
2. Devereux R.B., Wachtell K., Gerdts E., et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004, 292:2350-2356.
3. de Simone G., Gottdiener J.S., Chinali M., Maurer M.S. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008, 29:741-747.
4. Verdecchia P., Angeli F., Borgioni C., et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 2003, 16:895-899.
5. Hense H.W., Gneiting B., Muscholl M., et al. The association of body size and body composition with left ventricular mass: impacts for indexation in adults. J Am Coll Cardiol 1998, 32:451-457.
6. Henry R.M.A., Kamp O., Kostense P.J., et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon-The Hoorn Study. Kidney Int 2005, 68:673-679.
7. Stritzke J., Mayer B., Lieb W., et al. Haematocrit levels and left ventricular geometry: results of the MONICA Augsburg Echocardiographic Substudy. J Hypertens 2007, 25:1301-1309.
8. Dörr M., Wolff B., Robinson D.M., et al. The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metabol 2005, 90:673-677.
9. Völzke H., Schwahn C., Dörr M., et al. Inverse association between number of teeth and left ventricular mass in women. J Hypertens 2007, 25:2035-2043.
10. Sontia B., Touyz R.M. Magnesium transport in hypertension. Pathophysiology 2007, 14:205-211.
11. Sapna S., Ranjith S.K., Shivakumar K. Cardiac fibrogenesis in magnesium deficiency: a role for circulating angiotensin II and aldosterone. Am J Physiol Heart Circ Physiol 2006, 291:H436-440.
12. Finckenberg P., Merasto S., Louhelainen M., et al. Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression. J Hypertens 2005, 23:375-380.
13. Resnick L.M., Laragh J.H., Sealey J.E., Alderman M.H. Divalent cations in essential hypertension. Relation between serum ionized calcium, magnesium and plasma renin activity. N Engl J Med 1983, 309:888-891.
14. Völzke H., Alte D., Schmidt C.O., et al. Cohort profile: the study of Health in Pomerania. Int J Epidemiol 2010.
15. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108.
16. Arnold A.M., Kronmal R.A. Multiple imputation of baseline data in the Cardiovascular health study. Am J Epidemiol 2003, 157:74-84.
17. Schafer J.L., Graham J.W. Missing data: our view of the state of the art. Psychol Methods 2002, 7:147-177.
18. Dawson E.B., Frey M.J., Moore T.D., McGanity W.J. Relationship of metal metabolism to vascular mortality rates in Texas. Am J Clin Nutr 1978, 31:1188-1197.
19. Kesteloot H., Huang D.X., Li Y.L., Geboers J., Joossens J.V. The relationship between cations and blood pressure in People's Republic of China. Hypertension 1987, 9:654-659.
20. Jee S.H., Miller E.R., Guallar E., Singh V.K., Appel L.J., Klag M.J. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002, 15:691-696.
21. Touyz R.M., Milne F.J., Seftel H.C., Reinach S.G. Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents. S Afr Med J 1987, 72:377-381.
22. Hvarfner A., Bergström R., Mörlin C., Wide L., Ljunghall S. Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. J Hypertens 1987, 5:451-456.
23. Heggtveit H.A., Herman L., Mishra R.K. Cardiac necrosis and calcification in experimental magnesium deficiency. A light and electron microscopic study. Am J Pathol 1964, 45:757-782.
24. Weglicki W.B., Bloom S., Cassidy M.M., Freedman A.M., Atrakchi A.H., Dickens B.F. Antioxidants and the cardiomyopathy of Mg-deficiency. Am J Cardiovasc Pathol 1992, 4:210-215.
25. Kumaran C., Shivakumar K. Superoxide-mediated activation of cardiac fibroblasts by serum factors in hypomagnesemia. Free Radic Biol Med 2001, 31:882-886.
26. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 323:1706-1707.